Efficacy of Primary Collagen Cross-Linking with Photoactivated Chromophore (PACK-CXL) for the Treatment of Staphylococcus aureus–Induced Corneal Ulcers
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference31 articles.
1. Crosslinking treatment of progressive keratoconus: new hope.;Wollensak;Curr Opin Ophthalmol,2006
2. UVAriboflavin crosslinking as treatment for corneal melting.;Al-Sabai;Bull Soc Belge Ophtalmol,2010
3. . Antimicrobial efficacy of riboflavinUVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.;Martins;Invest Ophthalmol Vis Sci,2008
4. Infectious keratitis treated with corneal crosslinking.;Makdoumi;Cornea,2010
5. . Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis.;Moren;Cornea,2010
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Photoactivated Chromophore for Keratitis-Corneal Cross-linking (PACK-CXL)—A Scoping Review Based on Preclinical Studies;Translational Vision Science & Technology;2024-07-18
2. Evaluation of photoactivated chromophore for keratitis–corneal cross‐linking (PACK‐CXL) in feline infectious keratitis—patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study;Veterinary Ophthalmology;2024-05-05
3. Evaluation of risk factors for treatment failure in canine patients undergoing photoactivated chromophore for keratitis – corneal cross-linking (PACK-CXL): a retrospective study using additive bayesian network analysis;BMC Veterinary Research;2023-11-02
4. Photoactivated Chromophore Corneal Collagen Cross-Linking for Infectious Keratitis (PACK-CXL)—A Comprehensive Review of Diagnostic and Prognostic Factors Involved in Therapeutic Indications and Contraindications;Journal of Personalized Medicine;2022-11-16
5. Corneal cross-linking guards against infectious keratitis: an experimental model;International Ophthalmology;2022-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3